Faster drug approvals based on less evidence mean new tools are needed to track cost-effectiveness. As regulators approve more drugs faster, healt ...
Faster drug approvals based on less evidence mean new tools are needed to track cost-effectiveness. As regulators approve more drugs faster, healt ...
2021 was a standout year for drug development. The US FDA appr ...
A new generation of clinical research is arising, thanks to a profusion of health data and data-powered technologies such as in silico modeling. More data, by itself, does not guarantee better res ...
Control arms are key to reliably determining whether a new treatment works better than what already exists. The data they generate – from trial patients who receive a placebo, the standard of care (SO ...
How two distinct, yet complementary approaches could revolutionize R&D Mechanistic modeling and artificial intelligence (AI) are both transforming medicine. AI is being increasingly applied to drug ...